Jardiance (empagliflozin) is a brand-name drug that’s prescribed for type 2 diabetes and more. As with other drugs, Jardiance can cause side effects, such as vaginal yeast infections and urinary tract ...

Maryland regulators voted Monday to cap what government health plans pay for the Type 2 diabetes drug Jardiance, a move ...

Maryland's Prescription Drug Affordability Board voted to cap how much government agencies pay for Jardiance, saving about ...

Maryland’s prescription drug affordability board (PDAB) passed resolutions affirming that Eli Lilly and Boehringer Ingelheim’s Jardiance (empagliflozin) and AstraZeneca’s Farxiga (dapagliflozin) carry ...

The board will now oversee a process to lower the cost of the type 2 diabetes medicine Jardiance by January 2027.

Health care advocates on Wednesday hailed recent steps to limit how much state health plans will pay for a popular a Type 2 ...

Maryland's Prescription Drug Affordability Board voted to cap how much government agencies pay for Jardiance, a common ...

(The Center Square) – Negotiated lower Medicare costs for 10 popular prescription drugs went into effect Thursday. How much those savings will be passed on to Medicare Part D and applicable Advantage ...

A UC San Francisco analysis has found that the newer generation of much more effective diabetes medications are reaching only a fraction of the patients who are recommended to take them based on new ...